Rushad Patell
Overview
Explore the profile of Rushad Patell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
89
Citations
1153
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Patell R, Zwicker J, Singh R, Mantha S
Bleeding Thromb Vasc Biol
. 2024 Sep;
3(Suppl 1).
PMID: 39323613
The goal of machine learning (ML) is to create informative signals and useful tasks by leveraging large datasets to derive computational algorithms. ML has the potential to revolutionize the healthcare...
12.
Chrysafi P, Barnum K, Gerhard G, Chiasakul T, Narang A, McNichol M, et al.
J Thromb Haemost
. 2024 Aug;
22(12):3479-3489.
PMID: 39127323
Background: Optimal anticoagulation management in patients with myeloproliferative neoplasms (MPN) experiencing splanchnic vein thrombosis (SpVT) requires balancing risks of bleeding and recurrent thrombosis. Objectives: We conducted a systematic review and...
13.
Chiang C, Osataphan S, Chang Y, Chi K, Chiang C, Chang Y, et al.
Blood Adv
. 2024 Jul;
8(18):4803-4806.
PMID: 38985330
No abstract available.
14.
Fernandez Turizo M, Patell R, Zwicker J
Bleeding Thromb Vasc Biol
. 2024 Jun;
3(Suppl 1).
PMID: 38828226
Comprehensive protein analyses of plasma are made possible by high-throughput proteomic screens, which may help find new therapeutic targets and diagnostic biomarkers. Patients with cancer are frequently affected by venous...
15.
Lam B, Dodge L, Zerbey S, Robertson W, Rosovsky R, Lake L, et al.
Sci Rep
. 2024 May;
14(1):12010.
PMID: 38796561
Venous thromboembolism (VTE) is the leading cause of preventable death in hospitalized patients. Artificial intelligence (AI) and machine learning (ML) can support guidelines recommending an individualized approach to risk assessment...
16.
Bindal P, Patell R, Chiasakul T, Lauw M, Ko A, Wang T, et al.
J Thromb Haemost
. 2024 Apr;
22(7):2071-2080.
PMID: 38574863
Background: Chimeric antigen receptor T-cell (CAR T-cell) therapy is increasingly utilized for treatment of hematologic malignancies. Hematologic toxicities including thrombosis and bleeding complications have been reported. Accurate estimates for thrombotic...
17.
Lam B, Chrysafi P, Chiasakul T, Khosla H, Karagkouni D, McNichol M, et al.
Blood Adv
. 2024 Mar;
8(12):2991-3000.
PMID: 38522096
Venous thromboembolism (VTE) is a leading cause of preventable in-hospital mortality. Monitoring VTE cases is limited by the challenges of manual medical record review and diagnosis code interpretation. Natural language...
18.
Patell R, Cool J, Merchant E, Dodge L, Ricotta D, Persaud B, et al.
J Hosp Med
. 2024 Mar;
19(4):259-266.
PMID: 38472645
Background: In-hospital consultation is essential for patient care. We previously proposed a framework of seven specific consultation types to classify consult requests to improve communication, workflow, and provider satisfaction. Methods:...
19.
Sherry D, Patell R, Han H, Dodge L, Braun I, Buss M
J Pain Symptom Manage
. 2024 Feb;
67(6):471-477.e6.
PMID: 38417464
Context: Medical cannabis is increasingly considered for palliation of pain, nausea/vomiting, anorexia, and other symptoms. Objectives: We aimed to determine whether training in hospice and palliative medicine (HPM) adequately prepares...
20.
Agrawal S, Patell R, Dodge L, Pegher J, Coleman R, Waterhouse D, et al.
JCO Oncol Pract
. 2024 Feb;
20(6):861-868.
PMID: 38330269
Purpose: Little is known about the specific needs during training for hematology/oncology providers practicing in community-based settings. We conducted a national survey of hematologists/oncologists employed in community or academic-community hybrid...